NYSE:MED - New York Stock Exchange, Inc. - US58470H1014 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 674.48M | 1.07B | 1.60B | 1.53B | 934.80M | |||
Cost Of Goods | 176.70M | 296.20M | 458.20M | 398.50M | 237.00M | |||
Gross Profit | 497.77M | 775.85M | 1.14B | 1.13B | 697.80M | |||
Operating Expenses | 486.93M | 649.45M | 955.60M | 911.30M | 556.70M | |||
Research and Development | 4.40M | 4.60M | 4.50M | 4.40M | 2.80M | |||
Selling, General, and Administrative Expenses | 482.53M | 644.85M | 951.10M | 907.00M | 553.80M | |||
Operating Income | 10.85M | 126.40M | 184.80M | 216.20M | 141.20M | |||
Interest Income/Expense | 5.03M | 2.49M | -700.00K | -200.00K | 200.00K | |||
Other Income/Expense | -3.56M | -95.00K | 0.00 | 100.00K | -100.00K | |||
Non Recurring Items | N/A | N/A | N/A | N/A | -7.00M | |||
Income Before Taxes | 12.31M | 128.80M | 184.10M | 216.10M | 134.30M | |||
Income Tax | 4.99M | 29.38M | 40.50M | 52.10M | 31.40M | |||
Net Income | 7.33M | 99.42M | 143.60M | 164.00M | 102.90M | |||
EBITDA | 23.68M | 139.51M | 195.80M | 223.00M | 148.50M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 0.67 | 9.10 | 12.70 | 13.89 | 8.64 | |||
Non GAAP EPS | 2.48 | 9.11 | 13.55 | 13.89 | 9.16 | |||
Statistics | ||||||||
Gross Profit Margin | 73.80% | 72.37% | 71.34% | 73.89% | 74.65% | |||
Profit Margin | 1.09% | 9.27% | 8.98% | 10.75% | 11.01% | |||
Operating Profit Margin | 1.61% | 11.79% | 11.56% | 14.17% | 15.10% |
All data in USD